Clinical trials
Completed Muscular Atrophy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
243 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 9 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 6 |
| 2011 | 9 |
| 2012 | 11 |
| 2013 | 9 |
| 2014 | 13 |
| 2015 | 9 |
| 2016 | 10 |
| 2017 | 21 |
| 2018 | 16 |
| 2019 | 17 |
| 2020 | 16 |
| 2021 | 20 |
| 2022 | 20 |
| 2023 | 19 |
| 2024 | 11 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 243 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 11 |
| Maastricht University Medical Center | 7 |
| United States Army Research Institute of Environmental Medicine | 6 |
| Bispebjerg Hospital | 5 |
| McMaster University | 5 |
| University of Exeter | 5 |
| National Yang Ming Chiao Tung University | 4 |
| Tufts University | 4 |
| Amsterdam UMC, location VUmc | 3 |
| DLR German Aerospace Center | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy | 243 |
| Sarcopenia | 33 |
| Critical Illness | 22 |
| Muscle Weakness | 22 |
| Frailty | 8 |
| Muscular Disorders, Atrophic | 8 |
| Pulmonary Disease, Chronic Obstructive | 8 |
| Weight Loss | 8 |
| Cachexia | 7 |
| Muscular Atrophy, Spinal | 7 |
Trials
Showing 76 to 100 of 243. Each trial links to its page on Pharma Observatory.
143 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.